Harler Mary Beth 4
4 · IGM Biosciences, Inc. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
Harler Mary Beth
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-07-19+54,999→ 140,226 total - Disposition to Issuer
Stock Option (right to buy)
2024-07-19−200,000→ 0 totalExercise: $61.45Exp: 2031-10-11→ Common Stock (200,000 underlying) - Award
Common Stock
2024-07-19+25,001→ 165,227 total
Footnotes (3)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 200,000 shares of the Issuer's Common Stock and in exchange issued RSU grants of 54,999 shares and 25,001 shares.
- [F3]These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.